↓ Skip to main content

New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors

Overview of attention for article published in Frontiers in Pharmacology, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors
Published in
Frontiers in Pharmacology, April 2022
DOI 10.3389/fphar.2022.864088
Pubmed ID
Authors

Prabhakar Busa, Yaswanth Kuthati, Niancih Huang, Chih-Shung Wong

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 14%
Lecturer 3 7%
Student > Doctoral Student 3 7%
Unspecified 3 7%
Student > Bachelor 3 7%
Other 4 9%
Unknown 22 50%
Readers by discipline Count As %
Medicine and Dentistry 6 14%
Unspecified 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Nursing and Health Professions 1 2%
Other 5 11%
Unknown 23 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2022.
All research outputs
#14,027,302
of 23,755,107 outputs
Outputs from Frontiers in Pharmacology
#4,397
of 17,401 outputs
Outputs of similar age
#193,105
of 444,633 outputs
Outputs of similar age from Frontiers in Pharmacology
#253
of 1,262 outputs
Altmetric has tracked 23,755,107 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,401 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,633 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 1,262 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.